For investors
The opportunity, the technology and the clinical program behind Optima.
The opportunity
Optima is moving beyond retrospective research to population-level opportunistic screening. By transforming untapped imaging data into actionable medical insight, it addresses a global health challenge and is positioned as a cost-saving infrastructure layer for preventive medicine.
Optima sits at the intersection of exponential AI growth, big data and advanced healthcare analytics, within the global diagnostics and preventive medicine markets. This information is of particular relevance to investors, investment banks and capital-markets professionals.
Market dynamics
USD 741.85B
The preventive healthcare technologies and services market is projected to grow from USD 412.59 billion in 2026 to USD 741.85 billion by 2031 (12.45% CAGR).
Source: Preventive Healthcare Technologies And Services Market Size & Share Analysis – Growth Trends And Forecast (2026 – 2031); Mordor Intelligence; January 2026.
$1.490T
Inflation-adjusted U.S. projections (2022 USD) indicate that by 2050, annual healthcare costs for cardiovascular risk factors will more than triple ($400B to $1.344T), while costs for cardiovascular conditions will nearly quadruple ($393B to $1.490T). Productivity losses are projected to rise 54% ($234B to $361B), with stroke accounting for the largest absolute increase in costs. Global annual stroke costs exceed USD 890 billion and are projected to double by 2050.
Source: Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050; AHA Journals; June 2024. World Stroke Organization: Global Stroke Fact Sheet 2025; January 2025.
USD 90.62B
The global stroke diagnostic and therapeutic market is valued at USD 45.41 billion in 2026 and is expected to reach USD 90.62 billion by 2035 (7.98% CAGR).
Source: Stroke Diagnostic and Therapeutic Market Size; Precedence Research; September 2026.
36.91% CAGR
The global AI in medical imaging market is projected to reach USD 29.95 billion by 2034 (36.91% CAGR).
Source: AI in Medical Imaging Market Size; Fortune Business Insights; September 2026.
$2.2T / year
Strategic investments in disease prevention, early detection, and other proactive measures could save the US health care system up to $2.2 trillion a year by 2040. Even a modest improvement in detection rates can reduce emergency interventions, lower hospitalization costs and ease long-term care burden.
Source: Deloitte, Safeguarding Medicare: Proactive care could unlock $500B in annual program savings, September 2025.
Optima is not a generic AI imaging tool. Its competitive strength combines unique dataset aggregation, proprietary feature extraction for vascular silhouette detection beyond visible calcification, data network effects, clinical validation and deep integration within hospital workflows.
Optima Stroke is clinically validated and published. Optima Arteria, a development‑stage program, is preparing a clinical validation study with a prepared protocol and an established trial site, followed by extension across further anatomical regions (and, at the next stage, other imaging technologies, including MRI) and submission of new data to peer-reviewed journals.
Optima's diagnostic layer is designed to be relevant to many participants in the healthcare technology ecosystem, including imaging and PACS providers, MedTech companies and healthcare IT platforms. This creates several potential long-term strategic pathways for the technology.